Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2003
06/26/2003US20030119840 4-Heteroparyl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof
06/26/2003US20030119839 Indalones and other fused heterocylce-ones
06/26/2003US20030119838 Water-soluble phenylpyridazine compounds and compositions containing the same
06/26/2003US20030119837 Pharmaceutical composition for the treatment of CNS and other disorders
06/26/2003US20030119836 Cyclooxygenase inhibitors
06/26/2003US20030119835 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
06/26/2003US20030119834 Angiogenesis inhibitors; 3-alkyl-4-one quinazoline derivatives
06/26/2003US20030119832 Treatment of ocular disorders
06/26/2003US20030119831 3,7-dihydro-purine-2,6-dione derivatives as CRF receptor ligands
06/26/2003US20030119830 Monocyte chemoattractant protein-1 inhibitor compounds
06/26/2003US20030119829 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of PDE7B-mediated diseases and conditions
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119826 Neuroprotective treatment methods using selective iNOS inhibitors
06/26/2003US20030119825 Highly concentrated stable meloxicam solutions for needleless injection
06/26/2003US20030119824 Treatment of inflammatory bowel disease
06/26/2003US20030119823 5-(1,1-dioxido-1,2-thiazinan-2-yl)-n-(4-fluorobenzyl)-8-hydrox y-1,6-naphthyridine-7-carboxamide; preventing or treating hiv or aids
06/26/2003US20030119822 Bridged bicyclic amino acid-derived [1,4]benzodiazepine vasopressin receptor antagonists
06/26/2003US20030119821 Benzodiazepine-3-carboxamide derviatives
06/26/2003US20030119820 Substituted indoles
06/26/2003US20030119819 Anticancer agents
06/26/2003US20030119818 CRF antagonistic quino-and quinazolines
06/26/2003US20030119816 Cycline-dependent kinase protein inhibitors; antiproliferative agents
06/26/2003US20030119815 Lactams substituted by cyclic succinates as inhibitors of A-beta protein production
06/26/2003US20030119812 Administering a staurosporine derivative, especially N-benzoylstaurosporine, or salt thereof
06/26/2003US20030119811 Ion channel antagonists that are NMDA antagonists; treatment of migraine, depression, anxiety, schizophrenia, Parkinson's disease, or stroke.
06/26/2003US20030119809 Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
06/26/2003US20030119808 Coadministration of a sterol or 5-alpha-stanol absorption inhibitor (aryl-substituted azetidines) and a HMG-CoA reductase inhibitor, the latter being used sparingly in amounts insufficient to cause muscle degeneration.
06/26/2003US20030119805 Treating apoptosis. especially by administering zinc pyrithione, heterocyclic amines, dithiocarbamates and Vitamins.
06/26/2003US20030119804 Otic microbial combination for treatment of animals with ruptured tympanic membrane
06/26/2003US20030119802 Use particularly in the prophylaxis and treatment of respiratory diseases.
06/26/2003US20030119801 Stabilized tibolone compositions
06/26/2003US20030119800 Administering an ANGELS (Activators of Non-Genotropic Estrogen-like Signaling compound"ANGELS") compound to maintain or increase bone mass, bone density and/or bone strength.
06/26/2003US20030119799 Treating myocardial ischemia and angina pectoris comprising administering progesterone with or without estrogen.
06/26/2003US20030119798 Pharmaceutical composition for use as a contraceptive
06/26/2003US20030119797 Methods for selective immunomodulation
06/26/2003US20030119795 Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders
06/26/2003US20030119793 CAK inhibitors and uses thereof
06/26/2003US20030119792 Azo derivatives of 5-aminosalicylic acid containing an imidazolo(4,5-c)pyridine ring
06/26/2003US20030119791 Binding to nuclear receptor proteins; stimulating BMP-2 promoter activity
06/26/2003US20030119790 Substituted phenol compounds useful for anesthesia and sedation
06/26/2003US20030119789 Especially treating rheumatoid arthritis with compounds that inhibit proliferation and induce apoptosis.
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003US20030119786 Combinations for the treatment of immunoinflammatory disorders
06/26/2003US20030119784 Treating and preventing diarrhea and scours
06/26/2003US20030119783 Aqueous compositions containing metronidazole
06/26/2003US20030119781 Hyaluronic acid in soft gel form
06/26/2003US20030119780 Therapeutical treatments
06/26/2003US20030119777 Oligoribonucleotides and ribonucleases for cleaving RNA
06/26/2003US20030119776 Synthetic oligonucleotide sequence of 2 to 10 bases; treating autoimmune encephalomyelitis, cancer, and graft rejection, tissue rejection or cell rejection.
06/26/2003US20030119771 Especially inducers of osteoblast differentiation
06/26/2003US20030119769 Antisense oligonucleotide modulation of raf gene expression
06/26/2003US20030119766 Antisense modulation of apolipoprotein (A) expression
06/26/2003US20030119760 Water insoluble polymer, such as ethyl cellulose; and an optimizing agent, such as a Eudragit acrylic polymer, optionally containing lactose, dicalcium phosphate and/or tricalcium phosphate
06/26/2003US20030119757 Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)
06/26/2003US20030119756 E.g., lidocaine, topiramate, mexiletine and gabapentin, etc.
06/26/2003US20030119755 Methods for alleviating mucositis
06/26/2003US20030119753 Novel ascorbic acid compounds, methods of synthesis and application use thereof
06/26/2003US20030119752 Inhibiting particularly the activity of hepatitis C virus NS3-NS4A protease; peptidomimetics having a bridged bicyclic moiety at the P2 position.
06/26/2003US20030119749 Novel compounds possessing antibacterial, antifungal or antitumor activity
06/26/2003US20030119748 Use for treatment of inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury.
06/26/2003US20030119736 Increasing the availability of islet cell growth hormone to pancreatic cells wherein said islet cell growth hormone circulates at a level which is unresponsive to acute changes in glucose level.
06/26/2003US20030119735 Delivery system
06/26/2003US20030119732 CDDO-compounds and combination therapies thereof
06/26/2003US20030119729 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease
06/26/2003US20030119726 P-glycoproteins and uses thereof
06/26/2003US20030119724 Contain a hepatic ligand to direct an oligomer or "payload" to a hepatocyte intracellularly via a receptor-mediated, ligand-directed pathway; solid phase synthesis
06/26/2003US20030119718 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure
06/26/2003US20030119716 Methods for screening, treating and diagnosing G-protein coupled receptor-related disorders and compositions thereof
06/26/2003US20030119715 Prevent retinoid binding; antiaging agents; activation cell differentiation
06/26/2003US20030119714 Using neuropeptide y inhibitor; side effect reduction
06/26/2003US20030119684 Conditioning solution for contact lenses and a method of using the same
06/26/2003US20030119188 Novel compounds
06/26/2003US20030119104 Genetic engineered artificial chromosomes in plants, animals
06/26/2003US20030119076 B7-like polynucleotides, polypeptides, and antibodies
06/26/2003US20030119075 Anti-tissue factor antibodies with enhanced anticoagulant potency
06/26/2003US20030119036 Isolated nucleic acids; anticholesterol agents, cardiovascular disorders, antiinflammatory agents, antilipemic agents
06/26/2003US20030119029 Apoptosis, autoimmune diseases, antiproliferative agents, antiinflammatory agents, anticancer agents
06/26/2003US20030119019 Diagnoosis of Creutzfeldt-Jacob disease; incubation, binding,amplification cycles
06/26/2003US20030119013 Identification of essential genes of Aspergillus fumigatus and methods of use
06/26/2003US20030119000 Detection of hybrids; vision disorders; therapy using non-steroid antiinflammatory drug
06/26/2003US20030118993 Nucleic acid which is upregulated in human tumor cells, a protein encoded thereby and a process for tumor diagnosis
06/26/2003US20030118990 Novel estrogen-regulated G protein gamma subunit: compositions and methods of use
06/26/2003US20030118712 Matrix-forming composition containing pectin
06/26/2003US20030118678 Plant extracts as antiproliferative, viricides and antiparasitic agents
06/26/2003US20030118676 Novel herbal chemical composition for the treatment of cancer
06/26/2003US20030118673 Smilagenin and anzurogenin-D for the treatment of alzheimer's disease
06/26/2003US20030118672 Administering a stabilized rice bran derivative and a fortification agent; treating bone disorders
06/26/2003US20030118669 Novel substituted benzimidazole dosage forms and method of using same
06/26/2003US20030118667 Composition comprising camptothecin or a comptothecin derivative and a platin derivative for the treatment of cancer
06/26/2003US20030118661 Soft-shelled turtle, ageratum, ginseng and glucose; aging resistance
06/26/2003US20030118660 Residual solvent extraction method and microparticles produced thereby
06/26/2003US20030118656 Controlled release formulation of divalproex sodium
06/26/2003US20030118652 Methods and compositions for use of (S)-bisoprolol
06/26/2003US20030118651 Active material is cationic when the carrier is anionic, active material is anionic when the carrier is cationic; active agent is ionically linked to the carrier, transdermal by contacting the tissue surface
06/26/2003US20030118650 Tableted oral pharmaceutical dosage form, with enteric coating, containing a compound of benzimidazole labile in an acid medium
06/26/2003US20030118647 Extended release tablet of metformin
06/26/2003US20030118646 Enantiomers, drug for the treatment of narcolepsy, hypotension, attention-deficit hyperactivity disorder
06/26/2003US20030118645 Pharmaceutical compositions for rectal and vaginal administration
06/26/2003US20030118644 A solid forms comprising low molecular weight peptide-based thrombin inhibitor having pH dependent solubility, cellulose or starch as disintegrant fillers; immediate release
06/26/2003US20030118643 Preparing a fast-dissolving drug mixture from difficultly soluble active material, 70% dissolution rate, from an aqueous suspension containing the active substance and water-soluble adjuvants, dehydrating
1 ... 5425 5426 5427 5428 5429 5430 5431 5432 5433 5434 5435 5436 5437 5438 5439 5440 5441 5442 5443 5444 5445 ... 7860